(PR NEWSWIRE) BioShield Files 10KSB; Filing Reflects Positive Movement Forwar
BioShield Files 10KSB; Filing Reflects Positive Movement Forward
ATLANTA, Oct. 16 /PRNewswire/ --
BioShield Technologies, Inc. (OTC Bulletin Board: BSTI) announced that it
filed its annual 10KSB report Monday 10/15 after the close of the market.
Management stated, "The annual report had to include a tremendous amount of
legal and accounting information. It required all of the time legally
allotted to file as the company had to report on, among other things, the
restructuring of the company in December of 2000 including the need to refresh
and replace the board of directors, elimination of market overhang, the
elimination of eMD.com, the status of current issues legal or otherwise, and
the dividend/spinoff of HNS. BioShield has made great strides in moving
forward, and while the outlook for the future looks very strong, it still has
at least until the end of this calendar year before all outstanding issues are
resolved. The company has one mission: to remain focused, profitable and
sustain a high growth rate per quarter, thus creating a strong foundation for
growth, long-term stability and increased shareholder value."
Recently, BioShield reported its first profitable quarter, less
extraordinary items. The company continues to sign licensing and distribution
agreements for its patented antimicrobial molecule technology. Management has
estimated margins on existing contracts and on contracts under negotiation in
the 75-80% range. The company believes it is poised to emerge as one of the
leaders in the antimicrobial industry.
BioShield's patented E.P.A. approved technology is the world's first
residual antimicrobial chemical molecule. When applied to a surface, it kills
and prevents the regrowth of salmonella, e-coli, strep bacteria and over some
200+ other gram-positive/gram-negative organisms. It also destroys mold,
mildew, viruses and fungi. It continues to disinfect for one month to three
years, depending on the surface. Conventional antibacterial kill bacteria and
disinfect the surface, but as soon as they dry, they no longer work; they are
not a residual antimicrobial. BioShield's active molecule binds itself
molecularly to the surface, in a sense, creating a new protected surface.
Extended periods of time can go by, and depending on the surface, the original
application can continue to kill the viruses and germs that come in contact
with those surfaces. BioShield's antimicrobial is considered safe and does
not leach off into the environment.
Further information on BioShield and its line of products can be found by
visiting the firm's web site at bioshield.com or by calling
1-770-925-3653. The BioShield patents can be viewed online at:
delphion.com by conducting a search on the name BioShield.
Safe Harbor/Forward-looking Statements
Statements: in this news release that are not historical are forward-
looking statements. These forward-looking statements are subject to certain
risks and uncertainties that could cause actual results to differ materially
from those anticipated in any forward-looking statements, all of which are
difficult to predict and many of which are beyond the control of the company,
including areas such as: developing technologies; dependence on collaborative
partners; the inherent complexity and uncertainty regarding the development of
products; early-stage development of BioShield the result of research and
development efforts; future capital needs; uncertainty of additional funding;
government regulations; and other factors which are detailed in the company's
periodic reports and registration statements filed with the Securities and
Exchange Commission BioShield does not undertake to revise or update any
forward-looking statement to reflect events or circumstances that may arise
after the date hereof. BioShield is a trademark of BioShield, Technologies,
Inc.
MAKE YOUR OPINION COUNT - Click Here
tbutton.prnewswire.com
SOURCE BioShield Technologies, Inc.
-0- 10/16/2001
/CONTACT: BioShield Technologies Inc., +1-770-925-3653/
/Web site: bioshield.com /
(BSTI)
CO: BioShield Technologies, Inc.
ST: Georgia
IN: CHM BIO OTC
SU:
*** end of story *** |
